FDA Letter API

Artist Liquid Laboratories LLC

Letter data

Company
Artist Liquid Laboratories LLC
Recipient
Travis Bain and Robert Branting | Artist Liquid Laboratories LLC | United States | travis@artistliquidlabs.com
Issue date
2021-04-27
Posted date
Not available
FDA office
Center for Tobacco Products
Subject
Not available
Product
Tobacco
CMS ID
583546
Reference number
RW1901099
FEI
Not available
Inspection dates
Not available

Normalized citations

21 CFR: None found

21 U.S.C.: None found

Related FDA links

No related FDA letter link is present in the source index.

Full source text

CLOSEOUT LETTER Artist Liquid Laboratories LLC MARCS-CMS 583546 — April 27, 2021 More Warning Letters Warning Letters About Warning and Close-Out Letters Delivery Method: VIA Electronic Mail Reference #: RW1901099 Product: Tobacco Recipient: Recipient Name Travis Bain and Robert Branting Artist Liquid Laboratories LLC United States travis@artistliquidlabs.com Issuing Office: Center for Tobacco Products United States Dear Travis Bain and Robert Branting: The United States Food and Drug Administration’s (FDA) Center for Tobacco Products has completed an evaluation of your corrective actions included in your responses dated June 7, 2019 and April 15, 2021 in response to our Warning Letter dated June 7, 2019. Based on our evaluation, we note that your firm is no longer in operation and your websites identified in the Warning Letter have been inactivated. This letter does not relieve you or your firm from the responsibility of taking all necessary steps to ensure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. This letter also will not preclude any regulatory action should violations be observed in the future. Sincerely, /S/ David Rice Branch Chief Division of Promotion, Advertising, and Labeling Office of Compliance and Enforcement Center for Tobacco Products Content current as of: 04/30/2021 Regulated Product(s) Tobacco